In addition to supporting cancer cell survival, the RalB/Sec5/TBK1 cascade is also required for IRF3 nuclear translocation and Sendai virus-induced IFN-β promoter activation, suggesting that RalB/Sec5 effector complex, as an oncogenesis driver, could also be part of innate immune signaling. This evidence concerns the gene EXOC2 and cancer.